Prebiotics help mice fight melanoma by activating anti-tumor immunity

February 11, 2020

LA JOLLA, CALIF. - Feb. 11, 2020 - Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that two prebiotics, mucin and inulin, slowed the growth of melanoma in mice by boosting the immune system's ability to fight cancer. In contrast to probiotics, which are live bacterial strains, prebiotics are "food" for bacteria and stimulate the growth of diverse beneficial populations. The study, published today in Cell Reports, provides further evidence that gut microbes have a role in shaping the immune response to cancer, and supports efforts to target the gut microbiome to enhance the efficacy of cancer therapy.

The research specifically opens new avenues to address important unmet clinical needs in melanoma, as it highlights the possible impact of prebiotics on tumor growth control and therapy resistance.

"Earlier studies have demonstrated that prebiotics limit tumor growth, but until now the mechanism by which they do so has been unclear," says Ze'ev Ronai, Ph.D., professor in Sanford Burnham Prebys' Tumor Initiation and Maintenance Program and senior author of the study. "Our study shows for the first time that prebiotics limit cancer growth by enhancing anti-tumor immunity. The study supports further exploration of the potential benefits of prebiotics in treating cancer or augmenting current therapies."

Ronai cautions that these findings require much more study before considering any evaluation in people with cancer.

"Prebiotics represent a powerful tool to restructure gut microbiomes and identify bacteria that contribute to anti-cancer immunity," says Scott Peterson, Ph.D., professor in Sanford Burnham Prebys' Tumor Microenvironment and Cancer Immunology Program and co-corresponding author of the study. "The scientific advances we are making here are getting us closer to the idea of implementing prebiotics in cutting-edge cancer treatments."

Adds Jennifer Wargo, M.D., associate professor of Surgical Oncology and Genomic Medicine at the University of Texas MD Anderson Cancer Center, "Immunotherapies and targeted treatments such as MEK inhibitors are helping people with melanoma, but not everyone. While some patients respond to therapy, others do not. In addition, many patients develop resistance to treatment which requires alternate medicine combinations. Manipulating the microbiome with prebiotics might be a helpful addition to current treatment regimens, and today's finding should be further tested in independent models and systems."

In the study, the scientists set out to identify specific prebiotics that promote the growth of good bacteria and activate anti-tumor immunity. Based on previous studies conducted in a lab dish, they homed in on mucin, a protein that is part of the mucus found in our intestine and other tissues; and inulin, a fiber found in plants such as asparagus and onions.

The researchers then embarked on a series of studies that involved feeding healthy mice either mucin or inulin in their water and food, respectively, and then transplanting melanoma or colon cancer cells to determine the effect of the prebiotics. Their experiments showed that:"Our findings are a step forward in our understanding of how certain prebiotics affect tumor growth, but we are far from applying these to humans," says Ronai. "Future studies need to be conducted in more complex animal models of different genetic backgrounds and ages to address the complex nature of human tumors before we may consider evaluating these prebiotics in people."
-end-
The first author of the study is Yan Li, Ph.D., of Sanford Burnham Prebys. Additional study authors include Lisa Elmén and Igor Segota of Sanford Burnham Prebys, who contributed equally to the study; Roberto Tinoco, formerly of Sanford Burnham Prebys and currently of University of California Irvine; Yibo Xian, Rafael S. Segura Muñoz, Robert Schmaltz and Amanda Ramer-Tait, of University of Nebraska-Lincoln; Yongmei Feng, Yu Fujita, Linda M. Bradley, Tao Long, Scott N. Peterson, co-corresponding author, of Sanford Burnham Prebys; and Raphy Zarecki of Technion Integrated Cancer Center.

The study's DOI is 10.1016/j.celrep.2020.01.035.

Research reported in this press release was supported by the National Institutes of Health (NIH) (R35CA197465 and R01CA216187); the Melanoma Research Alliance (509524) and CDMRP (CA150892).

About Sanford Burnham Prebys Medical Research Institute

Sanford Burnham Prebys is a preeminent, independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For more than 40 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children's diseases, and is anchored by our NCI-designated Cancer Center and advanced drug discovery capabilities. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.

Sanford Burnham Prebys Medical Discovery Institute

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.